Abbott Laboratories India
US and Canadian anti-trust regulators conditionally approve Abbott-Alere merger
29 September 2017
Abbott Laboratories patches heart devices that could pose cybersecurity risks
31 August 2017
After price cap, Abbot seeks to withdraw stents from India
22 April 2017
Abbott, Alere agree to end legal battles, to go ahead with merger at lower price
15 April 2017
US regulators grant conditional approval to Abbott’s acquisition of St. Jude Medical
28 December 2016
Abbott seeks to terminate $5.8-bn acquisition of Alere
08 December 2016
European regulator conditionally approves Abbott's $25-bn deal for St Jude Medical
24 November 2016
Abbott offers EU concessions for antitrust approval of St Jude Medical acquisition
04 November 2016
Abbott Laboratories to sell eye care business to Johnson & Johnson for $4.325 bn
17 September 2016
Alere sues Abbott for completion of $5.8-bn merger
29 August 2016
Abbott to buy medical device maker St. Jude Medical for $25 bn
28 April 2016
P&G follows Pfizer, Abbot, ends sale of cold remedy
15 March 2016
India bans Pfizer, Abbot cough syrups; shares tank
14 March 2016
Abbott to buy rapid diagnostic testing provider Alere for $5.8 bn
02 February 2016
Sanofi, Pfizer, Abbott eye Mexican generic drug maker Rimsa
21 September 2015
New intraocular lens helps cataract-affected see better
07 August 2015
Abbott Laboratories to back Mylan-Perrigo deal
17 June 2015
Maruti joins Boeing, Abbott, Honeywell to back India’s IPR regime
04 June 2014
Abbott to acquire Chile's CFR Pharmaceuticals in a $2.9 bn deal
17 May 2014
Abbott Laboratories seeks to sell mature drugs worth more than $5 bn: report
05 May 2014
Abbott to enter laser cataract surgery market through OptiMedica acquisition
16 July 2013
Abbott to acquire stent maker IDEV Technologies for $310 mn
15 July 2013
Abbott buying OptiMedica for $400 mn to enter laser cataract surgery market
15 July 2013
Russia blocks Abbott Laboratories - Petrovax merger
20 April 2013
Pfizer, Novartis, Abbott in race for Brazil’s Ache Laboratorios: report
03 April 2013
Abbot spinoff AbbVie files to block EU regulator from releasing clinical trials data
11 March 2013
Abbott introduces bio-absorbable drug eluting vascular scaffold for cardiac use
19 December 2012
Abbott to pay $1.6 bn to settle Depakote epilepsy drug suits
09 May 2012
Abbott collaborates with Syngene to open first nutrition research centre in India
05 May 2012
Abbott to pay $1.3 bn to settle Depakote epilepsy drug claims
24 October 2011
Abott to split into two
19 October 2011
Lupin signs agreement with Abott Laboratories and others for Fenofibrate
27 April 2011
India rejects HIV drug patent application by Abbott Laboratories
03 January 2011
Solvay Pharma to merge with Abbott India in a 3:2 share swap
25 November 2010
Abbott recalls 5 million infant formulas over beetle larvae contamination
23 September 2010
Abbott to keep Piramal business separate after acquisition
11 September 2010
Abbott to hive off flu vaccine business of Solvay: report
29 June 2010
Abbott signs $575 million endometriosis drug deal with Neurocrine
16 June 2010
Abbott is India's biggest pharma firm after $3.7-bn Piramal deal
21 May 2010
Abbott signs agreement to market 24 Zydus Cadila products
12 May 2010
Abbott completes acquisition of Starlims Technologies
23 March 2010
Abbott receives US FDA approval for new cataract multifocal intraocular lens
11 March 2010
Abbott Laboratories to acquire Facet Biotech for $450 million
10 March 2010
Abbott bids for 20 per cent of Solvay India
17 February 2010
Bombay HC rejects plea to block Wockhardt deal with Abbott
18 January 2010
Abbott to acquire Starlims Technologies for $123 million
15 December 2009
Abbott to acquire Belgian drug company Solvay for $6.6 billion
29 September 2009
Abbott expands vision care portfolio; buys Visiogen
03 September 2009
Wockhardt sells its nutrition businesses to Abbott for $130 million
28 July 2009
Abbott Laboratories acquires Advanced Medical Optics in $2.8 billion cash-and-debt deal
12 January 2009
Abbott says its bioabsorbable drug-eluting stent could become next major breakthrough in interventional treatment
14 October 2008
Abbott Labs cuts 1,200 jobs as drug-coated heart stent market shrinks
05 December 2007
Abbott India to buy back shares at Rs 650
26 August 2006
Abbott onthe block
24 December 2001
Abbott revives growth prospects with BASF acquisition
18 December 2000
Abbott Labs acquires Alza for $ 7.3 billion
24 June 1999
Abbott Labs diversifying
01 September 1998
Abbott's new businesses, low-cost oppurtunism
01 September 1998
 search domain-b